All you need to know to "take control" after a diagnosis of DCIS of the Breast. Using the familiar image of a garden and a personal, plain English style, renowned breast cancer specialist Professor John Boyages, MD, PhD, walks you slowly through the stress and confusion of diagnosis, treatment and life after DCIS of the breast. In this book John Boyages provides you with all the information you or your family and friends need to take control, maximise your survival, and find your path to recovery. Learn how to: Find the right treatment team for you and avoid under- and over-treatment; Identify the key questions to ask your treatment team; Identify the treatment choices for your breast and armpit; Cope with menopause, sexuality, and fertility after treatment; Take control if cancer returns. The book divided into three coloured parts detailing the 20 points before, during and after treatment when you need to take control and make important decisions.

Empowers all women and their families who are faced with a diagnosis of breast cancer. At last there is a book that focuses on what a patient needs to know from the point of diagnosis. Renowned Australian breast cancer specialist John Boyages takes you through all the critical decision points in a personal, plain English style.

The book you can trust to support you at every stage of your treatment - and beyond Winner of best 'Popular Medicine' book, BMA Medical Book Awards 2019 Professor Trisha Greenhalgh, an academic GP, and Dr Liz O’Riordan, a Consultant Breast Cancer Surgeon, are not only outstanding doctors, but they have also experienced breast cancer first-hand. The Complete Guide to Breast Cancer brings together all the knowledge they have gathered as patients and as doctors to give you and your family a trusted, thorough and up-to-date source of information. Designed to empower you during your breast cancer treatment, it covers: -Simple explanations of every breast cancer treatment -Coping with the emotional burden of breast cancer -Frank advice about sex and relationships -Staying healthy during and after treatment -Dealing with the fear of recurrence -Living with secondary breast cancer Packed full of all the things the authors wished they’d known when they were diagnosed, and tips on how to cope with surgery, radiotherapy, chemotherapy and beyond, this is the only book you need to read to guide you through your breast cancer diagnosis. 'A much needed guide which is both humane and based on robust evidence.' – Macmillan Cancer Support

All you need to know to "take control" after a diagnosis of male breast cancer. Male breast cancer is not common and often underdiagnosed and undertreated. Using the familiar image of a garden and a personal, plain English style, renowned breast cancer specialist Professor John Boyages, MD, PhD, walks you slowly through the stress and confusion of diagnosis, treatment, and life after male breast cancer. In this book John Boyages provides you with all the information you or your family and friends need to take control, maximise your survival, and find your path to recovery. Learn how to: Know the difference between "man boobs" and male breast cancer; Have the right tests for an earlier diagnosis; Avoid under- or overtreatment; Ask your treatment team the right questions; Choose treatments for your breast and lymph nodes; Deal with stress, anxiety, fatigue, and sexuality during and after treatment; Understand when chemotherapy is really required; Get specific up-to-date information for male breast cancer and avoid pamphlets designed for females; Achieve a more positive state of mind through inspiring and motivating patient stories and key take-home messages. Some key features: "Traffic-light" colours guide you through treatment phases; 20 colour-coded "Control Points"; Clear end of chapter "Warning", "Tip" and "Remember" icons and summaries; End of chapter take home messages; 10 real-life patient stories; Plain English style with garden and other analogies to explain your breast cancer and its treatment; Over 50 images and graphically designed diagrams; Over 70 hand-picked web links; Detailed glossary, key references and index.

After her diagnosis of hormone-negative breast cancer, health journalist Patricia Prijatel did what any reporter would do: start investigating the disease, how it occurs, how it's treated, and how to keep it from recurring. While she learned that important research on triple-negative breast cancer (TNBC) was emerging, she found a noticeable lack of resources on the disease, which differs from hormone-positive breast cancer in important ways, including prognosis and treatment options. Triple-negative breast cancer disproportionately affects younger women and African-American women-and some forms of it can be more dangerous than other types of breast cancer. But there are many reasons to be hopeful, as Prijatel shows in this book. Surviving Triple-Negative Breast Cancer delivers research-based information on the biology of TNBC; the role of genetics, family history, and race; how to navigate treatment options; understanding a pathology report; and a plethora of strategies to reduce the risk of recurrence, including diet and lifestyle changes. In clear, approachable language, Prijatel provides a fact-filled guide based on a vast array of scientific studies. Woven throughout the book are stories of women who have faced TNBC. These are mothers, wives, daughters, and sisters who went through a variety of medical treatments and then got on with life--one competes in triathlons, two had babies after being treated with chemo, one got remarried in her 50s, and one just celebrated the 30th birthday of the son she was nursing when she was diagnosed. Writing with honesty and humor, Prijatel delivers an inspiring message--that TNBC is a disease to take seriously, with proper and occasionally aggressive treatment, but it is not automatically a killer. Most women diagnosed with the disease survive and go on to live full lives. Surviving Triple-Negative Breast Cancer is a roadmap for women who want to be empowered through their treatment and recovery.

Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.